Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MOREPeptide-MHC tetramers have been extensively applied for the detection and quantification of antigen-specific T cell populations and research MHC functions. Based on a powerful TCR development platform, scientists at Creative Biolabs have experience in the generation and optimization of TCR. We extend tetramerization technology to TCRs and have the ability to manufacture custom TCR tetramers that bind MHC-peptide complexes with high affinity.
Fig.1 TCR tetramer.
TCR tetramers serve as surface staining reagents for analysis of the MHC-peptide interface and the design of immunotherapeutics and vaccines. Compared to TCR monomers, TCR tetramers have higher affinities and can extend the half-life of TCR:pMHC interactions. TCR tetramers can provide new insight into MHC–mediated antigen presentation.
Fig.2 TCR monomer vs. TCR tetramer.
At Creative Biolabs, our team of scientists is dedicated to providing customized TCR tetramers to meet the needs of customers. Provide us with your candidate's TCR sequences or your specific TCR of interest, we can custom manufacture a TCR tetramer based on your needs.
A TCR Tetramer is prepared using biotinylated specific TCRs and fluorophore conjugated streptavidin which has four biotin binding sites.
Please contact us about your custom TCR tetramer request.
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
